SCHEMBL1029088

SCHEMBL1029088

CCCNCCOc1cc(C)c(NS(=O)(=O)c2ccc(OCC(F)F)cc2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.41
LMNA P02545 6/20 0.39
HTT P42858 5/20 0.39
TSHR P16473 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 4/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 5/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SQSTM1 Q13501 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
KMT2A Q03164 5/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4250907 0.99 PKM (0.40) PKMLMNAHTTTSHRSMN1; SMN2
SCHEMBL1031369 0.86 FFAR4 (0.48) PKMLMNAHTTTSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL4245551 0.85 FFAR4 (0.47) PKMLMNAHTTTSHRSMN1; SMN2
SCHEMBL1032212 0.85 PKM (0.35) PKMLMNAHTTTSHRSMN1; SMN2
SCHEMBL1031181 0.84 PIK3C3 (0.41) PKMLMNAHTTTSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL4242108 0.84 PKM (0.34) PKMLMNAHTTTSHRSMN1; SMN2
SCHEMBL1033640 0.84 PKM (0.39) PKMLMNAHTTTSHRSMN1; SMN2
SCHEMBL1031521 0.84 PKM (0.35) PKMLMNAHTTTSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL4243272 0.83 PIK3C3 (0.40) PKMLMNAHTTTSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL4244176 0.83 PKM (0.39) PKMLMNAHTTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed